Navigation Links
Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA)
Date:9/15/2008

illion in sponsored research agreements. In addition, the Foundation is committed to raising awareness and generating support for increased research efforts in SMA among the leaders of industry and government.

For more than 16 years Assay Designs has supplied the worldwide biomedical research community with immunoanalytical assay solutions for the precise quantification of biomarkers in a variety of sample matrices and species. Since 2005 ADI also provides the full spectrum of Stressgen(R) immunological reagents such as antibodies and proteins, to aid drug discovery and basic research. Assay Designs offers customers one-stop-shop custom development services from antibody and recombinant protein production to the development, validation, and manufacturing of biomarker assays, providing a seamless transition and scale up from pre-clinical to clinical applications.

The collaboration with SMAF is in alignment with Assay Designs' mission to provide researchers with high quality reagents and assays to expedite their efforts in developing new cures and improving the quality of life for patients.

About Assay Designs, Inc.

Based in Ann Arbor, MI, Assay Designs develops and manufactures immunoassay (ELISA) kits, luminescent reagents, antibodies, proteins, and extracts used for life sciences research. The company markets these products under the "Assay Designs" and "Stressgen" brand names. Researchers use the company's products to detect and quantify molecules that are important in inflammation, cell signaling, and cellular stress.


'/>"/>
SOURCE Assay Designs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay
2. Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo LLC
3. FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
4. Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors
5. Spectral announces exclusive distribution agreement in Russia for its EAA(TM) Sepsis Diagnostic Assay
6. Sensitivity Enhancements to Monograms Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy
7. Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting
8. Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
9. Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop(TM) II Molecular HIV Co-receptor Tropism Assay
10. Assay Designs(TM) Announces Collaboration with Medical University of South Carolina (MUSC)
11. HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... MA (PRWEB) , ... July 29, 2015 , ... ... Sherley says the company is making good progress in evaluating the full range ... adult tissue stem cells. Adult tissue stem cells perform the day-to-day renewal and ...
(Date:7/28/2015)... 28, 2015  PDL BioPharma, Inc. (PDL, or the ... Company will release its second quarter 2015 financial results ... August 5, 2015, after market close. PDL,s management will ... 4:30 p.m. Eastern Time to discuss the financial results. ... available via the webcast link on the PDL website. ...
(Date:7/28/2015)... , July 21, 2015 Research and ... of the "Biomedical Refrigerators and Freezers Market ... and Forecast 2014 - 2022" report to ... refrigerators and freezers market has been segmented based ... blood banks, and others. The others segment includes ...
(Date:7/28/2015)... N.J. , July 28, 2015  Moerae ... second Phase 1 clinical trial with MMI-0100, a ... is being developed for pulmonary disorders characterized by ... United Kingdom , is a ... further evaluating the safety and tolerability of MMI-0100 ...
Breaking Biology Technology:Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 4PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2
... - Rich media communications developer Sonic Foundry, ... $400,000 in positive cash flow in the fourth quarter ... bust. , ,Sonic Foundry, which has been building toward ... year-end financials during a webcast in which the company ...
... technologies from academic research centers, and building innovative companies ... able to tap deeper into federal government dollars. ... relations venture created by a collaboration between the Wisconsin ... the national economic development agency GSP Consulting . ...
... This is the third in a series of articles on developing ... Madison, Wis. - In Step 1 of ... property, and in Step 2 we discussed choosing a domain name. ... business name. Assuming that you have a viable domain name, then ...
Cached Biology Technology:Sonic Foundry reports first cash-positive quarter 2Sonic Foundry reports first cash-positive quarter 3New firm to help companies land federal dollars 2Early Stage, Step 3: Naming the entity 2Early Stage, Step 3: Naming the entity 3Early Stage, Step 3: Naming the entity 4
(Date:7/13/2015)... , July 13, 2015 Synaptics ... of human interface solutions, today announced sampling of ... and display driver integration (TDDI) product targeting smartphones ... first to combine Synaptics , best-in-class touch ... display driver technology developed in the company,s Japan ...
(Date:7/9/2015)... , July 9, 2015  Synaptics ... developer of human interface solutions, today announced ... industry,s first fully hardware encapsulated fingerprint sensor ... authentication technology is literally off the grid, ... biometric matching within the fingerprint sensor to ...
(Date:7/7/2015)... DUBLIN , June 30, 2015 ... ) has announced the addition of the ... their offering. To this date, fingerprint ... biometric technology and fingerprint sensors are well developed. ... capacitive sensing technology. The domain of ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... all strokes are the results of advanced atherosclerosis with damaged ... the direct and indirect annual cost of heart disease and ... cost of heart disease to increase from $523 to $1.126 ... expected that there will be more than 148 million of ...
... More than 1 in 270 people in the US are ... is infected. The economic cost estimates associated with HIV/AIDS exceed ... treatments have allowed people with HIV to live longer with ... the population with HIV in the US will be older ...
... of one of the proteins that serves as an on-off switch ... suggests there may be a sort of main power switch that ... discern light, set the heart racing, or detect pain. The ... by a research collaboration involving this year,s Nobel laureates in ...
Cached Biology News:Development of novel therapies for endothelial damage may heal atherosclerotic plaques 2Recreational use of HIV antiretroviral drug linked to its psychoactivity 2Structure of cell signaling molecule suggests general on-off switch 2